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function. Later, in 2009, Lavi and colleagues demonstrated 
that coronary segments with a higher degree of endothelial 
dysfunction were associated with necrotic plaque.
Non-invasive flow-mediated dilation and peripheral 
arterial tonometry
Intracoronary endothelial function assessment, while yield-
ing important information, is not feasible for large-scale 
application because it is expensive and requires catheteri-
sation. Looking for non-invasive alternatives, measurement 
of flow-mediated dilation (FMD) of the brachial artery was 
an important step forward. Measuring in a peripheral arte-
rial bed instead of in the coronary circulation is defendable 
from the viewpoint that atherosclerosis can be regarded as 
a systemic condition. FMD is non-invasive: increased flow 
through the artery is induced by reactive hyperaemia after 
a 5-minute occlusion of the arm, arterial diameter changes 
are measured by ultrasound. Peripheral arterial tonometry 
(PAT) was a next step; this non-invasive method also relies 
on reactive hyperaemia after a 5-minute occlusion of the 
arm but compares baseline and reactive hyperaemia ple-
thysmograms measured at a fingertip; hence, PAT is done in 
a microvascular bed instead of in a conduit artery. Because 
PAT is low risk, easy to perform and highly operator-inde-
pendent, it is suitable for large-scale measurement. Conse-
quently, there is much interest to validate this technique in 
all stages of atherosclerotic disease.
In the current issue of this Journal, Van den Heuvel and 
colleagues [1] publish a study that assesses the value of PAT 
to identify subjects at low risk among patients with new 
onset stable chest pain. Low risk was defined as no revascu-
larisation—PCI or CABG—within one year. In addition to 
PAT, patients underwent exercise testing, CT angiography 
The endothelium separates blood and the vascular wall. 
Endothelial stimulation by agonists or by shear stress has 
effects on the smooth musculature in the vessel wall by 
paracrine communication. After the finding that intact endo-
thelium is essential for acetylcholine to produce arterial 
vasodilation, various agents were discovered that stimulated 
the endothelium to produce endothelium-derived relaxing 
or contracting factors (EDRF/EDCF), the major EDRF 
being nitric oxide (NO). Additionally to vasodilation, NO 
inhibits platelet and monocyte adhesion and smooth mus-
cle cell proliferation and migration, all key factors in the 
genesis and progression of atherosclerosis. Thus, dysfunc-
tional endothelium, characterised by limited NO produc-
tion, has lost part of its vasodilatory function and promotes 
atherosclerosis.
In 1986, Ludmer and colleagues infused acetylcho-
line and the NO donor nitro-glycerine in the left anterior 
descending artery (LAD). Nitro-glycerine invariably caused 
LAD vasodilation but acetylcholine caused only vasodi-
lation in the normal arteries, while arteries with stenosis 
showed vasoconstriction or even temporal occlusion. This 
study paved the road for invasive assessment of coronary 
endothelial integrity and its association with atheroscle-
rosis in the coronary circulation. In 1989, Cox and col-
leagues measured flow-mediated LAD diameter changes 
by quantitative angiography, using adenosine infusions to 
increase blood flow. Dilation was markedly impaired in 
atherosclerotic vessels. However, all vessels dilated with 
nitro-glycerine. Hence, absence of flow-mediated dilation 
in atherosclerosis reflects impaired endothelial vasodilator 
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and calcium scoring. In contrast to the conventional diag-
nostics, PAT could not predict low risk.
Earlier, Rubinshtein and colleagues [2] had demon-
strated the predictive value of PAT for adverse cardiovas-
cular events (combined endpoint including cardiovascular 
death, myocardial infarction, revascularisation or cardiac 
hospitalisation) in a comparable patient group. However, 
separate prediction of revascularisation could also not be 
demonstrated. Later, Suessenbacher et al. [3] performed 
PAT in patients with significant coronary artery disease in at 
least one coronary vessel plus patients with < 70 % stenosis 
and a high cardiac risk profile. Average follow-up was 44 
months. In this study, PAT did not predict cardiovascular 
events. Recently, Matsuzawa and colleagues [4] performed 
PAT in a patient group referred for angiography for chest 
pain evaluation or abnormal stress test results. PAT results 
were significantly different in patients with and without sig-
nificant coronary artery disease.
Discussion
Negative or mixed conclusions require critical analysis. 
What can be expected of PAT for the assessment of coronary 
atherosclerosis? There are several concerns: (1) reactive 
hyperaemia is not uniquely endothelium dependent; (2) the 
site of measurement is not representative for the sites where 
atherosclerotic lesions emerge; (3) the microvasculature in 
the fingertip abundantly includes anastomoses; (4) endothe-
lial function is subject to many daily-life stimuli/events:
1. The mechanism of reactive hyperaemia is the same as 
that of autoregulation: with insufficient blood supply, 
metabolites accumulate in the interstitial space and 
cause arteriolar vasodilation (smooth muscle cell relax-
ation) by direct and by endothelium-mediated effects. 
E.g., smooth muscle cells as well as endothelial cells 
have adenosine receptors and, consequently, the me-
tabolite adenosine acts directly on smooth muscle but 
also indirectly, by acting on endothelial cells that in turn 
produce NO. Hence, microvascular vasodilation does 
not faithfully represent endothelial function because it 
is only partly endothelium dependent.
2. Disruption of laminar flow at branching points in the 
circulation influences the local endothelial layer via 
mechanotransduction, thus promoting conditions for 
atherosclerosis; the microvasculature in the fingertips is 
not representative for such atherosclerosis-prone sites in 
conduit arteries.
3. Vascular tone in the arteriovenous anastomoses in the 
finger is sympathetically controlled rather than by NO. 
This complicates interpretation of PAT measurements in 
terms of endothelial function.
4. Endothelial function is influenced by daily-life factors 
such as diet, smoking, hormone level changes during 
the menstrual cycle, diurnal and seasonal factors, stress, 
environmental factors like room and skin temperature, 
exercise, all at the cost of limited reproducibility of PAT 
measurements.
All mentioned factors weaken the link between PAT mea-
surements and endothelial function, thus hampering reliable 
atherosclerosis assessment and risk stratification by this 
technique. Nevertheless, a recent review considering a vari-
ety of measures of peripheral artery function [5] gives hope 
for future clinical use. Possibly, a particular setting (e.g., 
screening of young asymptomatic persons, risk assessment 
in chest pain with minimal coronary artery disease, risk 
assessment in advanced atherosclerosis) requires a particu-
lar technique, PAT, FMD or else. Anyway, more research 
is needed and it will take time before we know if coronary 
atherosclerosis will be at our fingertips.
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